New imaging technologies, digital platforms, AI systems, and groundbreaking radiopharmaceuticals are reshaping diagnostics ...
California clinics' doors are flying open, patients are lining up and ketamine is being prescribed off-label for everything ...
A session at the AHA Scientific Sessions 2025 focused on dilemmas related to antithrombotic therapy following catheter ablation in patients with AF.
Resistant hypertension remains a tough adversary in the fight against the global rise of cardiovascular disease, but updated guidance, new tools and new drugs on the horizon provide hope.Hypertension ...
Qihan's QT-019B program is supported by IND clearance for rSLE from both the US FDA and the China NMPA. The FDA has also granted Fast Track Designation for the SLE-ITP indication. Phase 1 enrollment ...
Data show deep, durable responses in the 50 million cell dose level cohort; initial data suggest substantial early improvement in three patients ...
Motixafortide alone and in combination with natalizumab (VLA-4 inhibitor) led to robust hematopoietic stem cell (HSC) mobilization predicting 16.9 million and 19.6 million cells/kg collected in a ...
Research presented at the 2025 ASH Annual Meeting sheds light on serious side effects that appear weeks or months after CAR T cell therapy for multiple myeloma.
Serious side effects, including neurotoxicity and intestinal inflammation, that appear weeks or months after patients receive CAR T cell therapy for multiple myeloma share a common immune root cause, ...
On a video call in early September, Sarah Tabrizi first saw the data that she and other researchers studying Huntington’s ...
Everyday Health on MSN
40 wellness gifts for loved ones with OCD, recommended by a therapist who gets it
Discover 40 soothing wellness gifts for people with OCD. See therapist-recommended mindfulness gifts that go beyond the ...
Presented in an oral session at the 67th American Society of Hematology Annual Meeting & Exposition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results